
Cell therapies need 2FA. This card represents the first 6529 research seed fund. We are developing engineered immune cell therapies with built-in biological security. By requiring two independent molecular signals before activation, these living medicines could act with unprecedented precision, limiting off-target effects while preserving therapeutic power. Funds from this card will seed a pilot study to test this concept.